• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中药和胃降逆汤治疗非糜烂性胃食管反流病不劣于口服奥美拉唑:一项随机、双盲、双模拟对照试验

Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail.

作者信息

Li Feng, Yuan Yali, Wu Di, Li Junxiang, Han Haixiao, Li Xiaohong, Hu Liming, Chen Runhua, Yao Yupu, Jiao Yao, Chen Huihui, Mao Tangyou, Xie Chune

机构信息

Beijing University of Chinese Medicine, Beijing, China.

Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, China.

出版信息

Evid Based Complement Alternat Med. 2022 Sep 22;2022:9647003. doi: 10.1155/2022/9647003. eCollection 2022.

DOI:10.1155/2022/9647003
PMID:36185085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9522514/
Abstract

OBJECTIVES

Conventional approaches for patients with nonerosive gastroesophageal reflux disease (NERD) were not satisfactory. This study aimed to evaluate the effectiveness and mechanisms of Chinese herbal medicine Hewei Jiangni Decoction (HWJND) as a novel and promising regimen for NERD.

METHODS

A total of 128 patients with NERD were randomly assigned to the Treatment group and Control group. The patients from the Treatment group were administered HWJND (81 g) plus dummy omeprazole (20 mg) daily for 8 weeks, and the others were given dummy HWJND granules (81 g) plus omeprazole (20 mg). The clinical efficacy was assessed using the gastroesophageal reflux disease questionnaire (GERD-Q) scale, patient reported outcomes (PRO) scale, and short form health survey 36 (SF-36) scale at week 4. Moreover, its pharmacological and molecular mechanisms were elucidated based on network pharmacology and molecular docking.

RESULTS

Due to case shedding and other reasons, 109 patients, including 56 in the Treatment group and 53 in the Control group completed this study. Our results showed that HWJND significantly improved heartburn, regurgitation, epigastric pain, nausea, and sleep disturbance, which led to a significant reduction of GERD-Q scores in NERD patients. In addition, PRO scores of NERD patients with HWJND administration were improved, and sufficient relief of physical role, body pain, general health, social function, and mental health on the SF-36 scale was also observed in patients after HWJND treatment. We further showed that the curative effect of HWJND was close to that of omeprazole, except for the better improvement of general health and social function. What's more, the main active ingredients of HWJND included quercetin, beta-sitosterol, naringenin, baicalein, and kaempferol were retrieved, and the protective effects of HWJND against NERD may be closely related to targets such as TNF, IL6, IL1B, MMP9, CXCL8, and EGFR, which were mainly enriched in IL-17 signaling pathway and TNF signaling pathway.

CONCLUSION

Our findings demonstrate that HWJND is noninferior to oral omeprazole for the treatment of patients with NERD, plays a therapeutic role through multiple targets and diverse pathways, and holds promise for complementary and alternative therapy for the treatment of NERD. This trial is registered with http://www.chictr.org.cn, Chinese Clinical Trials Registry [ChiCTR2200055960].

摘要

目的

传统治疗非糜烂性胃食管反流病(NERD)患者的方法并不令人满意。本研究旨在评估中药和胃降逆汤(HWJND)作为一种新型且有前景的NERD治疗方案的有效性及作用机制。

方法

128例NERD患者被随机分为治疗组和对照组。治疗组患者每日服用HWJND(81克)加安慰剂奥美拉唑(20毫克),持续8周,其余患者服用安慰剂HWJND颗粒(81克)加奥美拉唑(20毫克)。在第4周时,使用胃食管反流病问卷(GERD-Q)量表、患者报告结局(PRO)量表和健康调查简表36(SF-36)量表评估临床疗效。此外,基于网络药理学和分子对接阐明其药理及分子机制。

结果

由于病例脱落等原因,109例患者完成了本研究,其中治疗组56例,对照组53例。我们的结果表明,HWJND显著改善了烧心、反流、上腹痛、恶心和睡眠障碍,这导致NERD患者的GERD-Q评分显著降低。此外,服用HWJND的NERD患者的PRO评分得到改善,并且在HWJND治疗后的患者中,还观察到SF-36量表上身体功能、身体疼痛、总体健康、社会功能和心理健康的充分缓解。我们进一步表明,HWJND的疗效与奥美拉唑相近,除了在总体健康和社会功能方面改善更好。此外,检索到HWJND的主要活性成分包括槲皮素、β-谷甾醇、柚皮素、黄芩素和山奈酚,HWJND对NERD的保护作用可能与TNF、IL6、IL1B、MMP9、CXCL8和EGFR等靶点密切相关,这些靶点主要富集在IL-17信号通路和TNF信号通路中。

结论

我们的研究结果表明,HWJND在治疗NERD患者方面不劣于口服奥美拉唑,通过多个靶点和多种途径发挥治疗作用,有望成为NERD治疗的补充和替代疗法。本试验已在中国临床试验注册中心(http://www.chictr.org.cn)注册[ChiCTR2200055960]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/be4372bd4052/ECAM2022-9647003.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/b1bb637180f4/ECAM2022-9647003.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/c8ea0e9f9210/ECAM2022-9647003.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/0a05f0957535/ECAM2022-9647003.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/7a609dd31738/ECAM2022-9647003.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/ac6b522309fc/ECAM2022-9647003.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/788c530afb52/ECAM2022-9647003.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/be4372bd4052/ECAM2022-9647003.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/b1bb637180f4/ECAM2022-9647003.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/c8ea0e9f9210/ECAM2022-9647003.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/0a05f0957535/ECAM2022-9647003.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/7a609dd31738/ECAM2022-9647003.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/ac6b522309fc/ECAM2022-9647003.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/788c530afb52/ECAM2022-9647003.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226d/9522514/be4372bd4052/ECAM2022-9647003.007.jpg

相似文献

1
Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail.中药和胃降逆汤治疗非糜烂性胃食管反流病不劣于口服奥美拉唑:一项随机、双盲、双模拟对照试验
Evid Based Complement Alternat Med. 2022 Sep 22;2022:9647003. doi: 10.1155/2022/9647003. eCollection 2022.
2
Efficacy and safety of the Chinese herbal formula Hewei Jiangni recipe for NERD with cold-heat complex syndrome: study protocol for a double-blinded randomized controlled trial.和胃降逆方治疗寒热错杂型食管反流病的有效性和安全性:一项双盲随机对照试验的研究方案。
Trials. 2021 Aug 18;22(1):545. doi: 10.1186/s13063-021-05471-7.
3
JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study.健脾清化颗粒减少非糜烂性反流病患者质子泵抑制剂的剂量:一项多中心、随机、双盲、双模拟、非劣效性研究。
Phytomedicine. 2021 Jul 15;88:153584. doi: 10.1016/j.phymed.2021.153584. Epub 2021 May 3.
4
Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism.基于网络药理学的和胃降逆颗粒治疗胃食管反流病作用机制及实验验证
Drug Des Devel Ther. 2022 May 5;16:1349-1363. doi: 10.2147/DDDT.S348985. eCollection 2022.
5
The effect of Heweijiangni-decoction on esophageal morphology in a rat model of OVA-induced visceral hypersensitivity followed by acid exposure.和胃降逆汤对卵清蛋白诱导的内脏高敏反应继以酸暴露大鼠模型食管形态的影响。
Cell Mol Biol (Noisy-le-grand). 2019 Jun 30;65(5):73-78.
6
Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.蔓越莓(Phyllanthus emblica L.)在非糜烂性反流病中的疗效和安全性:一项双盲、随机、安慰剂对照临床试验。
J Integr Med. 2018 Mar;16(2):126-131. doi: 10.1016/j.joim.2018.02.008. Epub 2018 Feb 13.
7
Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.藻酸钠联合奥美拉唑治疗非糜烂性反流病的疗效:一项随机临床试验。
Dis Esophagus. 2012 Jul;25(5):373-80. doi: 10.1111/j.1442-2050.2011.01276.x. Epub 2011 Nov 2.
8
A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan.一项随机前瞻性研究,比较按需治疗与持续治疗6个月对日本胃食管反流病患者长期维持使用20毫克奥美拉唑疗效的影响。
Scand J Gastroenterol. 2014 Apr;49(4):409-17. doi: 10.3109/00365521.2013.878380. Epub 2014 Jan 21.
9
A randomized, controlled, double-blinded and double-dummy trial of the effect of tongjiang granule on the nonerosive reflux disease of and Gan-Wei incoordination syndrome.通降颗粒治疗肝胃不和型非糜烂性反流病的随机、对照、双盲双模拟临床试验
Chin J Integr Med. 2011 May;17(5):339-45. doi: 10.1007/s11655-011-0724-0. Epub 2011 May 25.
10
Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.乌珠俞汤治疗胃食管反流病的疗效:随机、双盲、安慰剂对照试验。
Phytomedicine. 2019 Mar 15;56:118-125. doi: 10.1016/j.phymed.2018.09.185. Epub 2018 Sep 18.

引用本文的文献

1
Herbal medicine for the treatment of non-erosive reflux disease: A systematic review and meta-analysis.草药治疗非糜烂性反流病:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Nov 8;103(45):e40269. doi: 10.1097/MD.0000000000040269.
2
Efficacy of Shugan Hewei formula combined with rabeprazole in refractory gastroesophageal reflux disease: randomized, double-blind, placebo-controlled trial.疏肝和胃方联合雷贝拉唑治疗难治性胃食管反流病的疗效:随机、双盲、安慰剂对照试验。
Eur J Med Res. 2024 Sep 19;29(1):466. doi: 10.1186/s40001-024-02030-z.
3
Topic Modeling Analysis of Chinese Medicine Literature on Gastroesophageal Reflux Disease: Insights into Potential Treatment.

本文引用的文献

1
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 study.全球、区域和国家胃食管反流病负担,1990-2019 年:来自 GBD 2019 研究的更新。
Ann Med. 2022 Dec;54(1):1372-1384. doi: 10.1080/07853890.2022.2074535.
2
JianpiQinghua granule reduced PPI dosage in patients with nonerosive reflux disease: A multicenter, randomized, double-blind, double-dummy, noninferiority study.健脾清化颗粒减少非糜烂性反流病患者质子泵抑制剂的剂量:一项多中心、随机、双盲、双模拟、非劣效性研究。
Phytomedicine. 2021 Jul 15;88:153584. doi: 10.1016/j.phymed.2021.153584. Epub 2021 May 3.
3
Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study.
基于中医文献的胃食管反流病主题建模分析:潜在治疗方法的启示
Chin J Integr Med. 2024 Dec;30(12):1128-1136. doi: 10.1007/s11655-024-3800-y. Epub 2024 Jun 8.
4
Current complementary and alternative therapy forgastroesophageal reflux disease.目前用于胃食管反流病的补充和替代疗法。
Gastroenterol Rep (Oxf). 2023 Oct 4;11:goad057. doi: 10.1093/gastro/goad057. eCollection 2023.
不同表型胃食管反流病食管活检组织中炎性细胞因子的基因表达谱:一项横断面研究
BMC Gastroenterol. 2021 May 3;21(1):201. doi: 10.1186/s12876-021-01707-7.
4
Highlighted role of "IL17 signaling pathway" in gastroesophageal reflux disease.“IL17信号通路”在胃食管反流病中的突出作用。
Gastroenterol Hepatol Bed Bench. 2020 Winter;13(Suppl1):S68-S74.
5
The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review.黄芩缓解炎症细胞因子的主要生物活性化合物:全面综述。
Biomed Pharmacother. 2021 Jan;133:110917. doi: 10.1016/j.biopha.2020.110917. Epub 2020 Nov 17.
6
Mucosal pathogenesis in gastro-esophageal reflux disease.胃食管反流病的黏膜发病机制。
Neurogastroenterol Motil. 2020 Dec;32(12):e14022. doi: 10.1111/nmo.14022. Epub 2020 Oct 28.
7
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD).胃食管反流病(GERD)的药物治疗管理
Expert Opin Pharmacother. 2021 Feb;22(2):219-227. doi: 10.1080/14656566.2020.1817385. Epub 2020 Sep 7.
8
-Sitosterol Alleviates Inflammatory Response via Inhibiting the Activation of ERK/p38 and NF-B Pathways in LPS-Exposed BV2 Cells.谷固醇通过抑制 LPS 暴露的 BV2 细胞中 ERK/p38 和 NF-B 通路的激活来减轻炎症反应。
Biomed Res Int. 2020 May 27;2020:7532306. doi: 10.1155/2020/7532306. eCollection 2020.
9
Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.胃食管反流病及质子泵抑制剂难治性症状的流行情况。
Gastroenterology. 2020 Apr;158(5):1250-1261.e2. doi: 10.1053/j.gastro.2019.12.014. Epub 2019 Dec 19.
10
IL-17 receptor-based signaling and implications for disease.IL-17 受体信号转导及其在疾病中的意义。
Nat Immunol. 2019 Dec;20(12):1594-1602. doi: 10.1038/s41590-019-0514-y. Epub 2019 Nov 19.